CIK 0001818844
- Non-accelerated filer
- Smaller reporting company
Dogwood Therapeutics, Inc.
Sign in to watch- Ticker
- DWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 854314201
- Phone
- +1 866-620-8655
- Business address
- 44 MILTON AVENUE, ALPHARETTA, GA, 30009
- Former names
- Virios Therapeutics, Inc., Virios Therapeutics, LLC
- 4 Open-market buy Director bought 8,827 shares at $5.66 ($49,997)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 5,000 shares at $5.52 ($27,615)
- 4 Open-market buy Director bought 942 shares at $6.32 ($5,951)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 382 shares at $6.36 ($2,429)
- 4/A Open-market buy Chief Executive Officer bought 15,675 shares at $6.17 ($96,757)
- 4 Open-market buy Chief Executive Officer bought 15,675 shares at $6.17 ($96,757)
- 4 Open-market buy VP of Finance bought 1,000 shares at $7.30 ($7,300)
- 4 Open-market buy Director bought 3,500 shares at $7.47 ($26,145)
- 4 Exercise or conversion Director acquired 1,602 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 6 · 117 filings